March 11, 2009 / 11:47 AM / in 9 years

Aeterna posts quarterly loss on revenue decline

TORONTO (Reuters) - Aeterna Zentaris Inc reported a quarterly loss on Wednesday, hurt by lower sales and royalties and falling manufacturing margins.

The biopharmaceuticals company said it lost C$14.5 million ($11.3 million), or 27 Canadian cents a share, during its fourth quarter, compared with a loss of C$13.6 million, or 26 Canadian cents a share, for the same time in the previous year.

Excluding a number of items including income tax adjustments, the company said it lost C$13.5 million, or 27 Canadian cents a share.

Revenue dropped 29.3 percent to C$7.2 million.

Analysts on average were expecting a loss of 26 Canadian cents a share and revenue of C$9.6 million, according to Reuters Estimates.

($1=$1.28 Canadian)

Reporting by Scott Anderson; Editing by Steve Orlofsky

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below